Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Previous close
¥10.70
Day range
¥10.27 - ¥10.98
Year range
¥7.06 - ¥20.55
Market cap
4.17B CNY
Avg Volume
3.27M
P/E ratio
-
Dividend yield
0.37%
Primary exchange
SHA
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 160.37M | 34.65% |
Operating expense | 117.01M | 4.68% |
Net income | 31.97M | 1,739.97% |
Net profit margin | 19.94 | 1,265.75% |
Earnings per share | — | — |
EBITDA | 36.41M | 953.62% |
Effective tax rate | 4.76% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 269.46M | -23.07% |
Total assets | 1.71B | 13.34% |
Total liabilities | 786.63M | 39.01% |
Total equity | 920.95M | — |
Shares outstanding | 405.93M | — |
Price to book | 4.78 | — |
Return on assets | 4.42% | — |
Return on capital | 5.85% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 31.97M | 1,739.97% |
Cash from operations | -3.90M | -137.00% |
Cash from investing | -55.37M | -229.77% |
Cash from financing | 15.98M | -37.98% |
Net change in cash | -43.29M | -154.81% |
Free cash flow | -85.53M | -159.92% |
About
Founded
Dec 11, 2009
Website
Employees
468
